Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$965,440
+$604,180 QoQ
Shares Held
3,448
+154.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#473
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CI INVESTMENTS INC. holds $485,219,155 across 15 Diagnostics & Research names. LH ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
470,263 | $235,771,057 | |
| 2 | DHR |
Danaher Corp /De/
|
753,723 | $143,569,157 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
338,366 | $65,379,078 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
26,329 | $13,943,575 | |
| 5 | NTRA |
Natera, Inc.
|
46,354 | $12,582,793 | |
| 6 | WAT |
Waters Corp /De/
|
13,140 | $4,928,025 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
6,187 | $3,257,084 | |
| 8 | A |
Agilent Technologies, Inc.
|
11,715 | $1,556,103 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $965,440 | 3,448 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $361,260 | 1,354 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $299,550 | 1,194 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $363,130 | 1,265 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $449,417 | 1,712 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $411,251 | 1,767 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $588,435 | 2,566 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,266,461 | 5,667 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,189,312 | 5,844 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||